The Effect of Oral Administration of Silymarin on Serum Levels of Tumor Necrosis Factor-α and Interleukin-1ß in Patients with Rheumatoid Arthritis.
Mehrdad ShavandiYasaman YazdaniShirin AsarArash MohammadiEhsan Mohammadi-NooriAmir KianiPublished in: Iranian journal of immunology : IJI (2023)
The addition of silymarin to the treatment regimen of patients with stable RA has no significant effect on the serum levels of TNF-α and IL-1β, however, this study needs further evaluation with a larger sample size.